These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5812007)

  • 1. Response of a "resistant" plasmacytoma to alkylating agents and x-ray in combination with the "excision" repair inhibitors caffeine and chloroquine.
    Gaudin D; Yielding KL
    Proc Soc Exp Biol Med; 1969 Sep; 131(4):1413-6. PubMed ID: 5812007
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of DNA repair inhibitors on e response of tumors treated with x-ray and alkylating agents.
    Gaudin D; Yielding KL; Stabler A; Brown J
    Proc Soc Exp Biol Med; 1971 May; 137(1):202-6. PubMed ID: 5581662
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES WITH MUSTARDS. V. IN VIVO FIXATION OF C14 OF LABELED ALKYLATING AGENTS BY BILATERALLY GROWN SENSITIVE AND RESISTANT TUMORS.
    WHEELER GP; ALEXANDER JA
    Cancer Res; 1964 Sep; 24():1331-7. PubMed ID: 14221791
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES WITH MUSTARDS. VII. EFFECTS OF ALKYLATING AGENTS IN VITRO AND IN VIVO UPON THE THERMAL PROPERTIES OF DEOXYRIBONUCLEIC ACIDS FROM SENSITIVE AND RESISTANT PLASMACYTOMAS.
    WHEELER GP; STEPHENS ZH
    Cancer Res; 1965 Apr; 25():410-6. PubMed ID: 14281108
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES WITH MUSTARDS. VI. EFFECTS OF ALKYLATING AGENTS UPON NUCLEIC ACID SYNTHESIS IN BILATERALLY GROWN SENSITIVE AND RESISTANT TUMORS.
    WHEELER GP; ALEXANDER JA
    Cancer Res; 1964 Sep; 24():1338-46. PubMed ID: 14221792
    [No Abstract]   [Full Text] [Related]  

  • 6. Some early effects of cyclophosphamide therapy on Fortner plasmacytoma.
    Tomisek AJ; Allan PW; Chesnutt F; Johnson BT
    Chem Biol Interact; 1972 Feb; 4(3):175-84. PubMed ID: 4550470
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nitrogen mustard and cyclophosphamide upon the synthesis of DNA in vivo and in cell-free preparations.
    Wheeler GP; Alexander JA
    Cancer Res; 1969 Jan; 29(1):98-109. PubMed ID: 5812632
    [No Abstract]   [Full Text] [Related]  

  • 8. Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster.
    Griswold DP; Schabel FM; Wilcox WS; Simpson-Herren L; Skipper HE
    Cancer Chemother Rep; 1968 Apr; 52(3):345-87. PubMed ID: 5670719
    [No Abstract]   [Full Text] [Related]  

  • 9. Iodine-123-iododeoxyuridine: a potential indicator of tumour response to treatment.
    Robins AB; Taylor DM
    Int J Nucl Med Biol; 1981; 8(1):53-63. PubMed ID: 7228519
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the DNA repair inhibitor chloroquine on the therapeutic response of Cytoxan sensitive plasmacytomas and host toxicity to treatment with Cytoxan.
    Stabler A
    Ala J Med Sci; 1971 Apr; 8(2):184-7. PubMed ID: 5096767
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of plasmacytoma].
    Fateh-Moghadam A
    Munch Med Wochenschr; 1973 May; 115(18):861-4. PubMed ID: 4800218
    [No Abstract]   [Full Text] [Related]  

  • 12. Deoxyribonucleic acid synthesis. I. Effect of in vivo cyclophosphamide treatment on the in vitro activity of the deoxyribonucleic acid synthetase system of sensitive and resistant plasmacytomas.
    Tomisek AJ; Irick MB; Allan PW
    Cancer Res; 1966 Jul; 26(7):1466-72. PubMed ID: 5911588
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
    Griswold DP; Simpson-Herren L; Schabel FM
    Cancer Chemother Rep; 1970 Oct; 54(5):337-46. PubMed ID: 5514623
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line.
    Frondoza CG; Trivedi SM; Humphrey RL
    Cancer Treat Rep; 1982 Jul; 66(7):1535-44. PubMed ID: 7093969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results and current biological bases of therapy of malignant hemoreticulopathies].
    Berceanu S; Gociu M; Geib R; Sighetea E; Dăncescu I; Segal E; Tănăsescu C
    Stud Cercet Med Interna; 1971; 12(3):211-28. PubMed ID: 5002655
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
    Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
    Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
    Morimoto M; Green D; Rahman A; Goldin A; Schein PS
    Cancer Res; 1980 Aug; 40(8 Pt 1):2762-7. PubMed ID: 6771004
    [No Abstract]   [Full Text] [Related]  

  • 18. Testicular plasmacytoma with bone dissemination without medullary plasmacytosis.
    Hou TY; Dai MS; Kao WY
    Ann Hematol; 2003 Aug; 82(8):518-520. PubMed ID: 12838369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DNA repair replication by DNA binding drugs which sensitize cells to alkylating agents and X-rays.
    Gaudin D; Gregg RS; Yielding KL
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):543-7. PubMed ID: 4636521
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural changes in mammalian cell DNA induced by low-dose x-ray damage and subsequent postirradiation incubation in the presence and absence of caffeine.
    Wun KL; Shafer RH
    Radiat Res; 1982 May; 90(2):310-20. PubMed ID: 7079465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.